Polaryx Therapeutics
PLYX
NASDAQ
IPO2026
about PLYX
Polaryx Therapeutics is a biotechnology company focused on advancing innovative gene regulation therapies targeting rare diseases and cancer.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $2.72 | $2.80 | $2.68 | $132.09M | 44.79K |